NCT04929028 2026-03-18Therapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerNational Cancer Institute (NCI)Phase 2 Recruiting40 enrolled
NCT06381154 2026-01-30Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic CancerMayo ClinicPhase 2 Recruiting25 enrolled